Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection

被引:3
|
作者
Sahoo, Bismin [1 ]
Mohanty, Srujana [1 ]
Gupta, Kavita [1 ]
Behera, Bijayini [1 ]
机构
[1] All India Inst Med Sci, Dept Microbiol, Bhubaneswar 751019, Odisha, India
关键词
SUSCEPTIBILITY; ENTEROBACTERIACEAE;
D O I
10.1016/j.diagmicrobio.2019.114961
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature
    Babiker, Ahmed
    Clarke, Lloyd
    Doi, Yohei
    Shields, Ryan K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (03)
  • [2] In Vitro Activity of Fosfomycin on Multidrug-Resistant Strains of Klebsiella pneumoniae and Klebsiella oxytoca Causing Urinary Tract Infection
    Ghayaz, Fatemeh
    Kelishomi, Fatemeh Zeynali
    Amereh, Samira
    Aali, Ehsan
    Javadi, Amir
    Peymani, Amir
    Nikkhahi, Farhad
    CURRENT MICROBIOLOGY, 2023, 80 (04)
  • [3] In Vitro Activity of Fosfomycin on Multidrug-Resistant Strains of Klebsiella pneumoniae and Klebsiella oxytoca Causing Urinary Tract Infection
    Fatemeh Ghayaz
    Fatemeh Zeynali Kelishomi
    Samira Amereh
    Ehsan Aali
    Amir Javadi
    Amir Peymani
    Farhad Nikkhahi
    Current Microbiology, 2023, 80
  • [4] Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
    Neuner, Elizabeth A.
    Sekeres, Jennifer
    Hall, Gerri S.
    van Duin, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5744 - 5748
  • [5] Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
    Dimopoulos, George
    Koulenti, Despoina
    Parker, Suzanne L.
    Roberts, Jason A.
    Arvaniti, Kostoula
    Poulakou, Garyphalia
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (03) : 201 - 210
  • [6] Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes
    Giancola, Stephanie E.
    Mahoney, Monica V.
    Hogan, Michael D.
    Raux, Brian R.
    McCoy, Christopher
    Hirsch, Elizabeth B.
    CHEMOTHERAPY, 2017, 62 (02) : 100 - 104
  • [7] Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichiacoli
    Patrice Nordmann
    Mustafa Sadek
    Laurent Poirel
    Trinad Chakraborty
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 689 - 690
  • [8] Reserve Antibiotics for Use in Multidrug-resistant Pathogens - Linezolid and Fosfomycin
    Katrin, Steul
    Rolf, Tessmann
    Klaus, Hollmann
    Martin, Weindel
    Klaus-Peter, Hunfeld
    Birgit, Strommenger
    Ursel, Heudorf
    GESUNDHEITSWESEN, 2022, 84 (04) : 356 - 356
  • [9] Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections A Randomized Clinical Trial
    Sojo-Dorado, Jesus
    Lopez-Hernandez, Inmaculada
    Rosso-Fernandez, Clara
    Morales, Isabel M.
    Palacios-Baena, Zaira R.
    Hernandez-Torres, Alicia
    de Lucas, Esperanza Merino
    Escola-Verge, Laura
    Bereciartua, Elena
    Garcia-Vazquez, Elisa
    Pintado, Vicente
    Boix-Palop, Lucia
    Natera-Kindelan, Clara
    Sorli, Luisa
    Borrell, Nuria
    Giner-Oncina, Livia
    Amador-Prous, Concha
    Shaw, Evelyn
    Jover-Saenz, Alfredo
    Molina, Jose
    Martinez-Alvarez, Rosa M.
    Duenas, Carlos J.
    Calvo-Montes, Jorge
    Silva, Jose T.
    Cardenes, Miguel A.
    Lecuona, Maria
    Pomar, Virginia
    de Santis, Lucia Valiente
    Yague-Guirao, Genoveva
    Lobo-Acosta, Maria Angeles
    Merino-Bohorquez, Vicente
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    JAMA NETWORK OPEN, 2022, 5 (01)
  • [10] Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli
    Nordmann, Patrice
    Sadek, Mustafa
    Poirel, Laurent
    Chakraborty, Trinad
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (04) : 689 - 690